Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

informed
November 27, 2024
9:22 pm

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

Active membership Required to Read Full Story

Star

September 13, 2024

Japanese documents reveal 21 horses died after export from Canada | CBC News

Newly released access to information documents from the Japanese government…

‘Bomb cyclone’ set to bring strong winds to B.C. coast, forecaster says

A special weather statement is in effect for much of…

Air Canada passengers repeatedly overcharged for baggage, but airline faces no fines

Rob Eedson of Ottawa figured he’d spring for a small…

This is an example headline 2

This is an example headline

Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

Health Canada approves Novo Nordisk’s obesity drug to reduce risk of non-fatal heart attack

Active membership Required to Read Full Story

Related Posts

Japanese documents reveal 21 horses died after export from Canada | CBC News

Read More >

‘Bomb cyclone’ set to bring strong winds to B.C. coast, forecaster says

Read More >

Air Canada passengers repeatedly overcharged for baggage, but airline faces no fines

Read More >

Subscribe Our Newsletter

Quick Links

Account